CLOVCLOVER HEALTH INVESTMENTS, CORP. /DEvs its industry peers
A metric-by-metric comparison of CLOVER HEALTH INVESTMENTS, CORP. /DE against SIC 6324 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CLOV본 종목 | $2.4B#5 | — | 6.3x#4 | 1.2x#5 | 40.3%#1 | -98.9%#5 | -4.4%#5 | -22.7%#5 | — | — | 48.2%#2 | — |
| UNH | $337.7B#1 | 24.2x#3 | 10.2x#5 | 0.8x#4 | 11.8%#3 | -16.3%#4 | 4.2%#1 | 36.5%#1 | 21.3%#1 | — | 14.4%#4 | 2.3%#1 |
| ELV | $88.4B#2 | 18.0x#2 | 2.0x#2 | 0.4x#3 | 12.5%#2 | -5.3%#3 | 3.6%#2 | 12.6%#3 | 9.3%#3 | — | 32.2%#3 | 1.7%#3 |
| CI | $72.5B#3 | 11.4x#1 | 1.7x#1 | 0.3x#1 | 11.2%#4 | 73.5%#1 | 3.3%#3 | 14.0%#2 | 9.5%#2 | — | -3.4%#5 | 2.2%#2 |
| HUM | $45.4B#4 | 40.3x#4 | 2.4x#3 | 0.3x#2 | 10.1%#5 | -1.6%#2 | 2.1%#4 | 6.4%#4 | 8.1%#4 | — | 51.0%#1 | 0.9%#4 |
Peer set: US filers sharing this company's SEC industry classification (SIC 6324). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-21.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice